Jin ZN - Search Results

1

Can axillary radiotherapy replace axillary dissection for patients with positive sentinel nodes? A systematic review and meta-analysis.

Zhao M, Liu WG, Zhang L, Jin ZN, Li Z, Liu C, Li DB, Ma Y, Zhang JW, Jin F, Chen B. Zhao M, et al. Among authors: jin f, jin zn. Chronic Dis Transl Med. 2017 Mar 1;3(1):41-50. doi: 10.1016/j.cdtm.2017.01.005. eCollection 2017 Mar 25. Chronic Dis Transl Med. 2017. PMID: 29063055 Free PMC article.

2

Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy.

Jin Z, Wang W, Jiang N, Zhang L, Li Y, Xu X, Cai S, Wei L, Liu X, Chen G, Zhou Y, Liu C, Li Z, Jin F, Chen B. Jin Z, et al. PLoS One. 2015 Jul 21;10(7):e0130286. doi: 10.1371/journal.pone.0130286. eCollection 2015. PLoS One. 2015. PMID: 26196284 Free PMC article.

3

TUFT1 is expressed in breast cancer and involved in cancer cell proliferation and survival.

Liu W, Zhang L, Jin Z, Zhao M, Li Z, Chen G, Sun L, Chen B. Liu W, et al. Oncotarget. 2017 Aug 24;8(43):74962-74974. doi: 10.18632/oncotarget.20472. eCollection 2017 Sep 26. Oncotarget. 2017. PMID: 29088838 Free PMC article.

4

Clinical significance of MSKCC nomogram on guiding the application of touch imprint cytology and frozen section in intraoperative assessment of breast sentinel lymph nodes.

Sun L, Chen G, Zhou Y, Zhang L, Jin Z, Liu W, Wu G, Jin F, Li K, Chen B. Sun L, et al. Oncotarget. 2017 Apr 27;8(44):78105-78112. doi: 10.18632/oncotarget.17490. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100452 Free PMC article.

5

Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses.

Jin Z, Xu L, Zhang L, Zhao M, Li D, Ye L, Ma Y, Ren S, Yu H, Wang D, Liang C, Chen B. Jin Z, et al. Am J Transl Res. 2018 Jun 15;10(6):1677-1689. eCollection 2018. Am J Transl Res. 2018. PMID: 30018709 Free PMC article.

6

Hierarchically Nanostructured Fe₃O₄/C Composite as a Promising Magnetic Targeted Drug Nanocarrier.

Wang DY, Liu Y, Zhang L, Jin ZN, Zhao ZQ, Yang Y, Ren SY, Yu HL, Zhao YJ, Peng NX, Wu M, Liang CY, Chen B. Wang DY, et al. Among authors: jin zn. J Nanosci Nanotechnol. 2019 Dec 1;19(12):7532-7538. doi: 10.1166/jnn.2019.16852. J Nanosci Nanotechnol. 2019. PMID: 31196257

7

A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis.

Geng N, Li Y, Zhang W, Wang F, Wang X, Jin Z, Xing Y, Li D, Zhang H, Li Y, Li X, Cheng M, Jin F, Li F. Geng N, et al. Int J Cancer. 2020 Feb 15;146(4):1139-1151. doi: 10.1002/ijc.32523. Epub 2019 Jun 20. Int J Cancer. 2020. PMID: 31219614

8

The Expression and Prognostic Significance of Claudin-8 and Androgen Receptor in Breast Cancer.

Zhang Y, Zheng A, Lu H, Jin Z, Peng Z, Jin F. Zhang Y, et al. Onco Targets Ther. 2020 Apr 23;13:3437-3448. doi: 10.2147/OTT.S242406. eCollection 2020. Onco Targets Ther. 2020. PMID: 32425547 Free PMC article.

9

Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer.

Suo HD, Tao Z, Zhang L, Jin ZN, Li XY, Ma W, Wang Z, Qiu Y, Jin F, Chen B, Cao Y. Suo HD, et al. Among authors: jin zn. Biomed Res Int. 2020 Jul 11;2020:7575862. doi: 10.1155/2020/7575862. eCollection 2020. Biomed Res Int. 2020. PMID: 32766313 Free PMC article.

10

MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer.

Tao Z, Suo H, Zhang L, Jin Z, Wang Z, Wang D, Wu M, Peng N, Zhao Y, Chen B. Tao Z, et al. Onco Targets Ther. 2020 Nov 27;13:12255-12268. doi: 10.2147/OTT.S263998. eCollection 2020. Onco Targets Ther. 2020. PMID: 33273831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters